Modern Development and Production of a New Live Attenuated Bacterial Vaccine, SCHU S4 <i>&#916;clpB</i>, to Prevent Tularemia.

Modern Development and Production of a New Live Attenuated Bacterial Vaccine, SCHU S4 ΔclpB, to Prevent Tularemia.

Conlan, J Wayne; Sjöstedt, Anders; Gelhaus, H Carl; Fleming, Perry; McRae, Kevan; Cobb, Ronald R; De Pascalis, Roberto; Elkins, Karen L.

Conlan JW; Department of Human Health and Therapeutics, National Research Council-Canada, Ottawa, ON K1A 0R6, Canada.
Sjöstedt A; Laboratory for Molecular Infection Medicine Sweden (MIMS), Department of Clinical Microbiology, Umeå University, SE-901 85 Umeå, Sweden.
Gelhaus HC; MRIGlobal, Kansas City, MO 64110, USA.
Fleming P; Department of Human Health and Therapeutics, National Research Council-Canada, Ottawa, ON K1A 0R6, Canada.
McRae K; Department of Human Health and Therapeutics, National Research Council-Canada, Ottawa, ON K1A 0R6, Canada.
Cobb RR; Ology Bioservices Inc., Alachua, FL 32615, USA.
De Pascalis R; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD 20993, USA.
Elkins KL; US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD 20993, USA.

Pathogens ; 10(7)2021 Jun 23.

Article en En | MEDLINE | ID: mdl-34201577